| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adamis Pharmaceuticals Corp | Director | Common Stock | 177,194 | $106,954 | $0.6036 | 25 May 2023 | By Versi Group, LLC |
| Adamis Pharmaceuticals Corp | Director | Employee Stock Option (Right to Buy) | 5,144 | 25 May 2023 | Direct | ||
| Adamis Pharmaceuticals Corp | Director | Series E Convertible Preferred Stock | 1,941 | 25 May 2023 | By Versi Group, LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000183988223013974-versi-jannine-2023-05-25 | Adamis Pharmaceuticals Corp | 25 May 2023 | 7 | $0 | 4 | Director | 30 May 2023, 18:14 |
| /report/000183988223013973-versi-jannine-2023-05-25 | Adamis Pharmaceuticals Corp | 25 May 2023 | 0 | $0 | 3 | Director | 30 May 2023, 18:13 |